Logo image of AGB2.DE

AGRANA BETEILIGUNGS AG (AGB2.DE) Stock Fundamental Analysis

FRA:AGB2 - Deutsche Boerse Ag - AT000AGRANA3 - Common Stock - Currency: EUR

10.55  +0.05 (+0.48%)

Fundamental Rating

5

Overall AGB2 gets a fundamental rating of 5 out of 10. We evaluated AGB2 against 56 industry peers in the Food Products industry. AGB2 has only an average score on both its financial health and profitability. AGB2 has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year AGB2 was profitable.
AGB2 had a positive operating cash flow in the past year.
AGB2 had positive earnings in 4 of the past 5 years.
Of the past 5 years AGB2 4 years had a positive operating cash flow.
AGB2.DE Yearly Net Income VS EBIT VS OCF VS FCFAGB2.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

AGB2 has a Return On Assets (2.46%) which is comparable to the rest of the industry.
With a Return On Equity value of 5.61%, AGB2 perfoms like the industry average, outperforming 41.07% of the companies in the same industry.
With a Return On Invested Capital value of 5.14%, AGB2 perfoms like the industry average, outperforming 48.21% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for AGB2 is below the industry average of 7.10%.
The last Return On Invested Capital (5.14%) for AGB2 is above the 3 year average (4.09%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.46%
ROE 5.61%
ROIC 5.14%
ROA(3y)0.77%
ROA(5y)1.16%
ROE(3y)1.92%
ROE(5y)2.52%
ROIC(3y)4.09%
ROIC(5y)3.22%
AGB2.DE Yearly ROA, ROE, ROICAGB2.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8 10

1.3 Margins

With a Profit Margin value of 1.71%, AGB2 is not doing good in the industry: 62.50% of the companies in the same industry are doing better.
In the last couple of years the Profit Margin of AGB2 has grown nicely.
With a Operating Margin value of 4.51%, AGB2 perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
In the last couple of years the Operating Margin of AGB2 has grown nicely.
AGB2 has a Gross Margin of 28.13%. This is in the lower half of the industry: AGB2 underperforms 73.21% of its industry peers.
AGB2's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.51%
PM (TTM) 1.71%
GM 28.13%
OM growth 3Y22.18%
OM growth 5Y16.61%
PM growth 3Y-9.94%
PM growth 5Y10.52%
GM growth 3Y-2.63%
GM growth 5Y-1.55%
AGB2.DE Yearly Profit, Operating, Gross MarginsAGB2.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so AGB2 is still creating some value.
Compared to 1 year ago, AGB2 has about the same amount of shares outstanding.
AGB2 has about the same amout of shares outstanding than it did 5 years ago.
The debt/assets ratio for AGB2 has been reduced compared to a year ago.
AGB2.DE Yearly Shares OutstandingAGB2.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
AGB2.DE Yearly Total Debt VS Total AssetsAGB2.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

An Altman-Z score of 2.55 indicates that AGB2 is not a great score, but indicates only limited risk for bankruptcy at the moment.
AGB2's Altman-Z score of 2.55 is fine compared to the rest of the industry. AGB2 outperforms 64.29% of its industry peers.
The Debt to FCF ratio of AGB2 is 2.25, which is a good value as it means it would take AGB2, 2.25 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 2.25, AGB2 belongs to the best of the industry, outperforming 91.07% of the companies in the same industry.
AGB2 has a Debt/Equity ratio of 0.45. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.45, AGB2 is in the better half of the industry, outperforming 66.07% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 2.25
Altman-Z 2.55
ROIC/WACC1.32
WACC3.9%
AGB2.DE Yearly LT Debt VS Equity VS FCFAGB2.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

A Current Ratio of 2.02 indicates that AGB2 has no problem at all paying its short term obligations.
AGB2 has a Current ratio of 2.02. This is in the better half of the industry: AGB2 outperforms 75.00% of its industry peers.
A Quick Ratio of 0.98 indicates that AGB2 may have some problems paying its short term obligations.
AGB2 has a Quick ratio (0.98) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.02
Quick Ratio 0.98
AGB2.DE Yearly Current Assets VS Current LiabilitesAGB2.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

AGB2 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 310.51%, which is quite impressive.
Measured over the past years, AGB2 shows a very strong growth in Earnings Per Share. The EPS has been growing by 20.64% on average per year.
Looking at the last year, AGB2 shows a small growth in Revenue. The Revenue has grown by 4.11% in the last year.
The Revenue has been growing by 9.16% on average over the past years. This is quite good.
EPS 1Y (TTM)310.51%
EPS 3Y2.79%
EPS 5Y20.64%
EPS Q2Q%-74.36%
Revenue 1Y (TTM)4.11%
Revenue growth 3Y14.13%
Revenue growth 5Y9.16%
Sales Q2Q%-7.66%

3.2 Future

Based on estimates for the next years, AGB2 will show a decrease in Earnings Per Share. The EPS will decrease by -1.32% on average per year.
AGB2 is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.57% yearly.
EPS Next Y-90.91%
EPS Next 2Y-22.71%
EPS Next 3Y-1.32%
EPS Next 5YN/A
Revenue Next Year-6.67%
Revenue Next 2Y-3.03%
Revenue Next 3Y-1.57%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AGB2.DE Yearly Revenue VS EstimatesAGB2.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
AGB2.DE Yearly EPS VS EstimatesAGB2.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 10.14, the valuation of AGB2 can be described as reasonable.
Based on the Price/Earnings ratio, AGB2 is valued a bit cheaper than 76.79% of the companies in the same industry.
When comparing the Price/Earnings ratio of AGB2 to the average of the S&P500 Index (28.79), we can say AGB2 is valued rather cheaply.
The Price/Forward Earnings ratio is 13.62, which indicates a correct valuation of AGB2.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AGB2 is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 21.38. AGB2 is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 10.14
Fwd PE 13.62
AGB2.DE Price Earnings VS Forward Price EarningsAGB2.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AGB2 is valued cheaply inside the industry as 83.93% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, AGB2 is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 1.98
EV/EBITDA 4.24
AGB2.DE Per share dataAGB2.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.49
EPS Next 2Y-22.71%
EPS Next 3Y-1.32%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.47%, AGB2 is a good candidate for dividend investing.
AGB2's Dividend Yield is rather good when compared to the industry average which is at 3.23. AGB2 pays more dividend than 96.43% of the companies in the same industry.
AGB2's Dividend Yield is rather good when compared to the S&P500 average which is at 2.51.
Industry RankSector Rank
Dividend Yield 6.47%

5.2 History

The dividend of AGB2 decreases each year by -3.86%.
Dividend Growth(5Y)-3.86%
Div Incr Years1
Div Non Decr Years2
AGB2.DE Yearly Dividends per shareAGB2.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

AGB2's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DPN/A
EPS Next 2Y-22.71%
EPS Next 3Y-1.32%
AGB2.DE Yearly Income VS Free CF VS DividendAGB2.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

AGRANA BETEILIGUNGS AG

FRA:AGB2 (4/15/2025, 7:00:00 PM)

10.55

+0.05 (+0.48%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)01-14 2025-01-14
Earnings (Next)05-09 2025-05-09/amc
Inst Owners4.26%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap659.27M
Analysts48.89
Price Target11.92 (12.99%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.47%
Yearly Dividend0.92
Dividend Growth(5Y)-3.86%
DPN/A
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.46%
PT rev (3m)-5.18%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-52.7%
EPS NY rev (3m)-82.59%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.08%
Valuation
Industry RankSector Rank
PE 10.14
Fwd PE 13.62
P/S 0.17
P/FCF 1.98
P/OCF 1.98
P/B 0.57
P/tB 0.63
EV/EBITDA 4.24
EPS(TTM)1.04
EY9.86%
EPS(NY)0.77
Fwd EY7.34%
FCF(TTM)5.33
FCFY50.52%
OCF(TTM)5.33
OCFY50.52%
SpS60.6
BVpS18.53
TBVpS16.72
PEG (NY)N/A
PEG (5Y)0.49
Profitability
Industry RankSector Rank
ROA 2.46%
ROE 5.61%
ROCE 9.27%
ROIC 5.14%
ROICexc 5.46%
ROICexgc 5.84%
OM 4.51%
PM (TTM) 1.71%
GM 28.13%
FCFM 8.8%
ROA(3y)0.77%
ROA(5y)1.16%
ROE(3y)1.92%
ROE(5y)2.52%
ROIC(3y)4.09%
ROIC(5y)3.22%
ROICexc(3y)4.33%
ROICexc(5y)3.41%
ROICexgc(3y)4.69%
ROICexgc(5y)3.76%
ROCE(3y)7.37%
ROCE(5y)5.81%
ROICexcg growth 3Y36.17%
ROICexcg growth 5Y23.54%
ROICexc growth 3Y40.14%
ROICexc growth 5Y26.3%
OM growth 3Y22.18%
OM growth 5Y16.61%
PM growth 3Y-9.94%
PM growth 5Y10.52%
GM growth 3Y-2.63%
GM growth 5Y-1.55%
F-Score7
Asset Turnover1.44
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 2.25
Debt/EBITDA 1.69
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 108.5%
Profit Quality 513.04%
Current Ratio 2.02
Quick Ratio 0.98
Altman-Z 2.55
F-Score7
WACC3.9%
ROIC/WACC1.32
Cap/Depr(3y)56.18%
Cap/Depr(5y)72.61%
Cap/Sales(3y)2.69%
Cap/Sales(5y)3.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)310.51%
EPS 3Y2.79%
EPS 5Y20.64%
EPS Q2Q%-74.36%
EPS Next Y-90.91%
EPS Next 2Y-22.71%
EPS Next 3Y-1.32%
EPS Next 5YN/A
Revenue 1Y (TTM)4.11%
Revenue growth 3Y14.13%
Revenue growth 5Y9.16%
Sales Q2Q%-7.66%
Revenue Next Year-6.67%
Revenue Next 2Y-3.03%
Revenue Next 3Y-1.57%
Revenue Next 5YN/A
EBIT growth 1Y4.5%
EBIT growth 3Y39.45%
EBIT growth 5Y27.29%
EBIT Next Year2.31%
EBIT Next 3Y14.05%
EBIT Next 5YN/A
FCF growth 1Y1027.89%
FCF growth 3Y7.53%
FCF growth 5YN/A
OCF growth 1Y1027.89%
OCF growth 3Y11.8%
OCF growth 5Y9.75%